Sean Mason | March 31, 2016 | SmallCapPower
A battered silver miner produced some good news Thursday, while a popular healthcare play was under the weather. Here’s some small stocks making big moves on Thursday, March 31, 2016 (as of 4 pm EST):
Americas Silver Corporation (TSX: USA) shares surged 30% to $0.24 on Thursday after the silver miner announced that consolidated silver production for 2016 is expected to be between 2.5 – 3.0 million silver ounces and 5.0 – 5.6 million silver equivalent ounces, while silver cash costs are projected to fall about 25% to between $9.00 – $10.00 per ounce with all-in sustaining costs projected to decline approximately 30%.
As well, shares of Dynasty Metals & Mining Inc. (TSX: DMM) plunged 50% to $0.155 as the resource explorer/developer said that towards the end of the fourth quarter of 2015 and into the first quarter of 2016 to date, both tonnage and grade at its Zaruma Gold Project in Ecuador dropped significantly due to several factors including, amongst other things, a reduced number of trained miners available to work at the Zaruma mine.
GeneNews Limited (TSX: GEN), meanwhile, reported that it has entered into a collaboration agreement with JTS Health Partners. The national healthcare management consulting and professional services firm will accelerate adoption of GeneNews’ menu of proprietary cancer tests, including its lead ColonSentry blood-test for assessing an individual’s current risk for colorectal cancer. GeneNews stock moved up 52% to $0.175 following the announcement.
In addition, shares of Patient Home Monitoring (TSXV: PHM) slid 25% to $0.275 as the healthcare service company said due to continuing Medicare reimbursement reductions and market dynamics impacting all providers in the industry, the business experienced a decline in revenues. It added that a business acquired in September 2013, Logimedix, is no longer good fit.
Finally, Callidus Capital Corporation (TSX: CBL) shares jumped 29% to $13.38 after the alternative lender announced that its fiscal 2015 revenue increase 73%, while its net income rose 48% from 2014. The Company added that it plans to buy back up to $50 million of its common stock at a price of $14 per share.
Hi, did you know SmallCapPower accepts blog submissions? You can contact me here
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. The Reader should apply his/her own judgment in making any use of any Content, including, without limitation, the use of any information contained therein as the basis for any conclusions. The Reader bears responsibility for his/her own investment research and decisions. Before making any investment decision, it is strongly recommended that you seek outside advice from a qualified investment advisor. SmallCapPower/Ubika Research does not provide or guarantee any financial, legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or information source.